Simultaneous detection of cyclopiazonic acid and aflatoxin B1 by HPLC in methanol/water mobile phase

A simple procedure for the simultaneous detection of cyclopiazonic acid (CPA) and aflatoxin B1 from fungal extracts is presented, using a methanol and water mobile phase and fluorescence detection. This methodology has been tested with standard solutions of both mycotoxins CPA and Aflatoxin B1 and with methanolic extracts of Aspergillus section Flavi strains, previously characterized for their mycotoxin production profile. Previously available methodology required the use of two different chromatographic runs for these mycotoxins, with distinct columns and detectors (fluorescence detection with a post-column photochemical derivatization (PHRED) for aflatoxin B1 and UV detection for CPA). The proposed method detects both mycotoxins in a single run. Data from these assays will be presented and discussed.

Detección de genotixicidad en cerdos inducida por la ingesta de Aflatoxina B1

En cerdos la micotoxicosis representa uno de los problemas de contaminación ambiental más frecuente. La aflatoxina B1 (AFB1) producida por ciertas cepas de A. flavus y A. parasiticus, es un agente genotóxico, ya que al ingerir alimento contaminado, los metabolitos de AFB1 inducen daño cromosómico. En función de este problema se plantean las siguientes hipótesis de trabajo: 1. La ingesta de alimentos contaminados con AFB1 inducen daño cromosómico en cerdos. 2. La inducción, frecuencia y tipo de daño cromosómico es dependiente del tiempo de ingesta de AFB1. En este trabajo se evalúa el potencial genotóxico in vivo de la AFB1, mediante tres métodos distintos: Análisis de aberraciones cromosómicas, Ensayo de micronúcleos y Electroforesis en gel de células individuales. Se evaluarán dos grupos de cerdos en etapa postdestete, uno control y otro alimentado con pienso ad líbitum, con AFB1 a una determinada concentración. Se tomarán muestras de sangre a los 15, 30, 45 y 60 días. En concordancia con los antecedentes bibliográficos, se espera detectar la ocurrencia de daño cromosómico inducido por la ingesta de AFB1 a una determinada dosis. El efecto genotóxico debería ser detectado desde las tres técnicas elegidas para su estudio. Se espera poder establecer el tipo preponderante de daño inducido por la ingesta de AFB1 en cerdos posdestete, la sensibilidad de las diferentes técnicas empleadas para su detección y determinar si existe relación entre el tipo e intensidad de daño cromosómico y el tiempo de ingesta de AFB1. En virtud que Río Cuarto y la región es una zona agrícola-ganadera, donde la explotación porcina es de interés económico y la ocurrencia reiterada de brotes de micotoxicosis, plantea la necesidad de evaluar el potencial genotóxico de las micotoxinas. Considerando que gran parte de la información publicada sobre la toxicidad se refiere a estudios en animales experimentales de laboratorio, que pueden no reflejar sus efectos en seres humanos y en animales de granja, se considera relevante evaluar la toxicidad, particularmente la genotoxicidad en animales a campo y sus posibles consecuencias para la salud y producción porcina. El abordaje de la evaluación del daño genotóxico inducido por AFB1 desde tres ensayos distintos permitirá establecer cuál de éstos métodos reúne las condiciones más ventajosas en cuento a: sensibilidad, tiempo requerido, validez estadística, sencillez y economía, para ser el método de elección en posteriores estudios.

Seletividade de avermectin-B1 (MK-936) ao Trichogramma demoraesi Nagaraja, 1983 (Hym. , Trichogrammatidae), em condições de laboratório

Foi conduzido um estudo, em condições de laboratório, para se determinar alguns parâmetros relativos à seletividade de avermectin-B1 (MK-936) ao Trichogramma demoraesi Nagajara, 1983 (Hym., Trichogrammatidae), parasito de ovos de diversas espécies de pragas agrícolas. Observou-se que o produto na formulação 1,8% CE, nas dosagens de 0,1; 0,2; 0,4 e 0,8 ml/l não afetava o desenvolvimento pré-marginal do parasito, quando este ainda se encontrava no interior dos ovos parasitados. O mesmo fato foi observado quando se utilizaram dosagens extremamente elevadas, da ordem de 8,0 ml/l. Não ocorreu, também, mortalidade significativa de adultos do parasito que ovipositaram em ovos de Anagasta kuehniella (Zeller, 1879) (Lep., Pyralidade) previamente tratados com o inseticida. A ação de contacto de avermectin-B1, quando aplicada nas paredes internas dos frascos de criação, não ficou evidenciada, pela dificuldade de se discriminar seus efeitos dos da acetona usada como solvente e que, mesmo aplica da sozinha, acarretou uma mortalidade significativa de adultos. Este fato pode estar associado aos 0,001% de resíduos não voláteis do solvente em questão, embora se tornem necessários estudos mais detalhados para se verificar esta hipótese. Malathion na dosagem de 1,5 ml/l apresentou-se extremamente tóxico para T. demoraesi em todos os estudos realizados. Concluiu-se que avermectin-B1 apresenta características de seletividade para esta espécie, com potencialidade de utilização em programas de controle integrado de pragas, em locais onde sobrevivam populações nativas ou introduzidas deste parasito.

Variation d'expression des récepteurs hormonaux et d'HER-2 dans l'évolution du cancer du sein : quelles implications en pratique clinique [Hormone receptors and HER-2 changes during breast cancer progression: clinical implications].

Breast cancer remains a major public health problem. Even if there is an increase in this cancer curability, metastatic breast cancer remains a lethal disease in the vast majority of cases. Therapeutic advances in the chemotherapeutic and targeted therapies fields induced an increase in survival, however the proportion of long survivors remains low. Phenotypic instability, an early process initiated during tumour progression, and continued on the metastatic stage of the disease, can be one of the putative hypotheses explaining these results. An increasing amount of scientific data are pledging for a reanalysis of the phenotypic profile regarding hormone receptors and HER-2 status of metastatic lesions in order to identify drugable targets and allow individualisation of the treatment of these metastatic breast cancer patients. Phenotypic changes between the primary tumour and the paired metastatic lymph nodes are a challenging pitfall, raising the question of which site has to be assessed in the adjuvant treatment decision process. This article presents a comprehensive analysis of the frequency of theses phenotypic changes altogether with new modalities to evaluate this phenotypic status.

Les récepteurs nucléaires PPARs (Peroxisome Proliferator Activated Receptors) : Trois isotypes pour de multiples fonctions.

Les récepteurs nucléaires font partie d'une superfamille de facteurs de transcription qui regroupe en particulier les récepteurs des hormones stéroïdes et thyroïdiennes, de la vitamine D3 et des rétinoïdes [1]. Ces facteurs de transcription sont impliqués dans de nombreuses fonctions cellulaires comme le développement embryonnaire, la différenciation cellulaire et le contrôle du métabolisme. Ce sont des protéines importantes en recherche médicale puisque un grand nombre d'entre elles sont impliquées dans des pathologies telles que le cancer, le diabète ou les syndromes de résistance aux hormones. À ce jour, cette superfamille comprend différents membres, dont l'activité est modulée par la présence de ligands spécifiques. Néanmoins, pour nombre d'entre eux, aucun ligand endogène spécifique n'a encore été identifié. Ceux-là sont appelés récepteurs orphelins. Orphelins lors de leur découverte il y a dix ans, les PPARs (Peroxisome proliferator-activated receptors) ont été particulièrement étudiés depuis, permettant de leur attribuer des ligands et des fonctions qui les placent au coeur de nombreuses régulations métaboliques.

The naturally occurring food mycotoxin fumonisin B1 impairs myelin formation in aggregating brain cell culture.

The effects of subchronical applications of the mycotoxin Fumonisin B1 (FB1) were analyzed in vitro, using aggregating cell cultures of fetal rat telencephalon as a model. As cells in the aggregates developed from an immature state to a highly differentiated state, with synapse and compact myelin formation, it was possible to study the effects of FB1 at different developmental stages. The results showed that FB1 did not cause cell loss and it had no effects on neurons. However it decreased strongly the total content of myelin basic protein, the main constituent of the myelin sheath, during the myelination period (DIV 18-28). The loss of myelin was not accompanied by a loss of oligodendrocytes, the myelinating cells. However FB1 had effects on the maturation of oligodendrocytes, as revealed by a decrease in the expression of galactocerebroside, and on the compaction of myelin, as shown by a reduction of the expression of the mnyelin/oligodendrocyte glycoprotein MOG. The content of the cytoskeletal component glial fibrillary acidic protein (GFAP) was decreased in differentiated astrocytes, exclusively, while neurons were not affected by 40 microM of FB1 applied continuously for 10 days. In summary, FB1 selectively affected glial cells. In particular, FB1 delayed oligodendrocyte development and impaired myelin formation and deposition.

B1-insensitive T2 preparation for improved coronary magnetic resonance angiography at 3 T.

At 3 T, the effective wavelength of the RF field is comparable to the dimension of the human body, resulting in B1 standing wave effects and extra variations in phase. This effect is accompanied by an increase in B0 field inhomogeneity compared to 1.5 T. This combination results in nonuniform magnetization preparation by the composite MLEV weighted T2 preparation (T2 Prep) sequence used for coronary magnetic resonance angiography (MRA). A new adiabatic refocusing T2 Prep sequence is presented in which the magnetization is tipped into the transverse plane with a hard RF pulse and refocused using a pair of adiabatic fast-passage RF pulses. The isochromats are subsequently returned to the longitudinal axis using a hard RF pulse. Numerical simulations predict an excellent suppression of artifacts originating from B1 inhomogeneity while achieving good contrast enhancement between coronary arteries and surrounding tissue. This was confirmed by an in vivo study, in which coronary MR angiograms were obtained without a T2 Prep, with an MLEV weighted T2 Prep and the proposed adiabatic T2 Prep. Improved quantitative and qualitative coronary MRA image measurement was achieved using the adiabatic T2 Prep at 3 T.

A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro.

We describe the transcriptional potentiation in estrogen responsive transcription extracts of the Xenopus vitellogenin B1 gene promoter through the formation of a positioned nucleosome. Nuclease digestion and hydroxyl radical cleavage indicate that strong, DNA sequence-directed positioning of a nucleosome occurs between -300 and -140 relative to the start site of transcription. Deletion of this DNA sequence abolishes the potentiation of transcription due to nucleosome assembly. The wrapping of DNA around the histone core of the nucleosome positioned between -300 and -140 creates a static loop in which distal estrogen receptor binding sites are brought close to proximal promoter elements. This might facilitate interactions between the trans-acting factors themselves and/or RNA polymerase. Such a nucleosome provides an example of how chromatin structure might have a positive effect on the transcription process.

Functional interaction between the estrogen receptor and CTF1: analysis of the vitellogenin gene B1 promoter in yeast.

Eukaryotic gene expression depends on a complex interplay between the transcriptional apparatus and chromatin structure. We report here a yeast model system for investigating the functional interaction between the human estrogen receptor (hER) and CTF1, a member of the CTF/NFI transcription factor family. We show that a CTF1-fusion protein and the hER transactivate a synthetic promoter in yeast in a synergistic manner. This interaction requires the proline-rich transactivation domain of CTF1. When the natural estrogen-dependent vitellogenin B1 promoter is tested in yeast, CTF1 and CTF1-fusion proteins are unable to activate transcription, and no synergy is observed between hER, which activates the B1 promoter, and these factors. Chromatin structure analysis on this promoter reveals positioned nucleosomes at -430 to -270 (+/-20 bp) and at -270 to - 100 (+/-20 bp) relative to the start site of transcription. The positions of the nucleosomes remain unchanged upon hormone-dependent transcriptional activation of the promoter, and the more proximal nucleosome appears to mask the CTF/NFI site located at - 101 to -114. We conclude that a functional interaction of hER with the estrogen response element located upstream of a basal promoter occurs in yeast despite the nucleosomal organization of this promoter, whereas the interaction of CTF1 with its target site is apparently precluded by a nucleosome.

Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity.

Transcriptional activity relies on coregulators that modify the chromatin structure and serve as bridging factors between transcription factors and the basal transcription machinery. Using the DE domain of human peroxisome proliferator-activated receptor gamma (PPARgamma) as bait in a yeast two-hybrid screen of a human adipose tissue library, we isolated the scaffold attachment factor B1 (SAFB1/HET/HAP), which was previously shown to be a corepressor of estrogen receptor alpha. We show here that SAFB1 has a very broad tissue expression profile in human and is also expressed all along mouse embryogenesis. SAFB1 interacts in pull-down assays not only with PPARgamma but also with all nuclear receptors tested so far, albeit with different affinities. The association of SAFB1 and PPARgamma in vivo is further demonstrated by fluorescence resonance energy transfer (FRET) experiments in living cells. We finally show that SAFB1 is a rather general corepressor for nuclear receptors. Its change in expression during the early phases of adipocyte and enterocyte differentiation suggests that SAFB1 potentially influences cell proliferation and differentiation decisions.

SA2RAGE: a new sequence for fast B1+ -mapping.

At high magnetic field strengths (≥ 3T), the radiofrequency wavelength used in MRI is of the same order of magnitude of (or smaller than) the typical sample size, making transmit magnetic field (B1+) inhomogeneities more prominent. Methods such as radiofrequency-shimming and transmit SENSE have been proposed to mitigate these undesirable effects. A prerequisite for such approaches is an accurate and rapid characterization of the B1+ field in the organ of interest. In this work, a new phase-sensitive three-dimensional B1+-mapping technique is introduced that allows the acquisition of a 64 × 64 × 8 B1+-map in ≈ 20 s, yielding an accurate mapping of the relative B1+ with a 10-fold dynamic range (0.2-2 times the nominal B1+). Moreover, the predominant use of low flip angle excitations in the presented sequence minimizes specific absorption rate, which is an important asset for in vivo B1+-shimming procedures at high magnetic fields. The proposed methodology was validated in phantom experiments and demonstrated good results in phantom and human B1+-shimming using an 8-channel transmit-receive array.

Determinants of vitellogenin B1 promoter architecture. HNF3 and estrogen responsive transcription within chromatin.

The liver-specific vitellogenin B1 promoter is efficiently activated by estrogen within a nucleosomal environment after microinjection into Xenopus laevis oocytes, consistent with the hypothesis that significant nucleosome remodeling over this promoter is not a prerequisite for the activation by the estrogen receptor (ERalpha). This observation lead us to investigate determinants other than ERalpha of chromatin structure and transcriptional activation of the vitellogenin B1 promoter in this system and in vitro. We find that the liver-enriched transcription factor HNF3 has an important organizational role for chromatin structure as demonstrated by DNase I-hypersensitive site mapping. Both HNF3 and the estrogen receptor activate transcription synergistically and are able to interact with chromatin reconstituted in vitro with three positioned nucleosomes. We propose that HNF3 is the cellular determinant which establishes a promoter environment favorable to a rapid transcriptional activation by the estrogen receptor.

Transcriptional potentiation of the vitellogenin B1 promoter by a combination of both nucleosome assembly and transcription factors: an in vitro dissection.

The Xenopus laevis vitellogenin B1 promoter was assembled into nucleosomes in an oocyte extract. Subsequent RNA polymerase II-dependent transcription from these DNA templates fully reconstituted in chromatin in a HeLa nuclear extract was increased 50-fold compared with naked DNA. Remarkably, under specific conditions, production of a high level of transcripts occurred at very low DNA (1 ng/microliter) and HeLa nuclear protein (1.6 micrograms/microliters) concentrations. When partially reconstituted templates were used, transcription efficiency was intermediate between that of fully reconstituted and naked DNA. These results implicate chromatin in the process of the transcriptional activation observed. Depletion from the oocyte assembly extract of an NF-I-like factor which binds in the promoter region upstream of the TATA box (-114 to -101) or deletion from the promoter of the region interacting with this factor reduced the transcriptional efficiency of the assembled templates by a factor of 5, but transcription of these templates was still 10 times higher than that of naked DNA. Together, these results indicate that the NF-I-like factor participates in the very efficient transcriptional potentiation of the vitellogenin B1 promoter which occurs during nucleosome assembly.